This content is machine translated Endometrial Cancer Dostarlimab in everyday clinical practice: initial experiences with diagnostics and therapy Patients with primary advanced or recurrent endometrial cancer have a poor prognosis, particularly in the long-term course of treatment with carboplatin plus paclitaxel. This can be significantly improved with the…
